<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03892629</url>
  </required_header>
  <id_info>
    <org_study_id>2018YFC1313601003</org_study_id>
    <nct_id>NCT03892629</nct_id>
  </id_info>
  <brief_title>Baduanjin Exercise for Patients With GOLD 2-3 Stable COPD on Pulmonary Rehabilitation</brief_title>
  <official_title>Baduanjin Exercise for Patients With GOLD 2-3 Stable Chronic Obstructive Pulmonary Disease on Pulmonary Rehabilitation: A Prospective, Randomized, Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ShuGuang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>ShuGuang Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic Obstructive Pulmonary Disease (COPD) is a disease with a very high morbidity and
      mortality rate. When the lung function drops lower and lower, patients will bear great
      affliction physically and mentally. How to improve the quality of life in patients with COPD
      is a hot topic in the study of COPD now. Baduanjin, as one of the traditional Chinese qigong
      exercises, has the features of generous stretch, soft consistency, dynamic but static, which
      is an appropriate movement pattern for COPD patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To investigate the efficacy of Baduanjin exercise for patients with stable chronic
      obstructive pulmonary disease on phase II~III. A prospective, randomized, controlled clinical
      trial was designed.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2019</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>St. George's respiratory questionnaire (SGRQ)</measure>
    <time_frame>Baseline, 3 months, 6 months</time_frame>
    <description>Evaluating the changes of impact on quality of life</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Six-minute walk test (6MWT)</measure>
    <time_frame>Baseline, 3 months, 6 months</time_frame>
    <description>Testing patients changes on walking distance and accompanies symptoms in 6 minutes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pulmanory function indicators (FEV1/FVC, FEV1pred%)</measure>
    <time_frame>Baseline, 3 months, 6 months</time_frame>
    <description>Assessing changes of airway limitation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified British medical research council questionnaire (mMRC)</measure>
    <time_frame>Baseline, 1 month, 2 months, 3 months, 6 months</time_frame>
    <description>Evaluating the severity of dyspnea, totally has 5 grade from 0-4, the higher grade represent a severer symptom</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>COPD assessment test (CAT)</measure>
    <time_frame>Baseline, 1 month, 2 months, 3 months, 6 months</time_frame>
    <description>Assessing the quality of life, the total score ranges from 0-40, the higher score represent a worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Times of acute exacerbation</measure>
    <time_frame>Baseline, 1 month, 2 months, 3 months, 6 months</time_frame>
    <description>Recording the frequency of acute exacerbation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-rating anxiety scale (SAS)</measure>
    <time_frame>Baseline, 3 months, 6 months</time_frame>
    <description>Evaluating the stage of anxiety, the total score ranges from 20-80, the higher score represent a worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-rating depression scale (SDS)</measure>
    <time_frame>Baseline, 3 months, 6 months</time_frame>
    <description>Evaluating the stage of depression, the total score ranges from 20-80, the higher score represent a worse outcome</description>
  </secondary_outcome>
  <other_outcome>
    <measure>The main TCM symptoms</measure>
    <time_frame>Baseline, 1 month, 2 months, 3 months, 6 months</time_frame>
    <description>The changes of scores of TCM syndromes, the total score ranges from 0-15, the higher score represent a worse outcome</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Baduanjin exercise group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group received Baduanjin exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Instrument rehabilitation group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in this group received rehabilitation by using tri-ball respiratory trainer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Baduanjin Exercise and Instrument Rehabilitation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in this group received both instrument rehabilitation and Baduanjin exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants in this group only received routine drug-treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Baduanjin exercise</intervention_name>
    <description>Participants received Baduanjin exercise. Each Baduanjin exercise session lasts 30 minutes and continues twice a day, 5 times per week for 12 weeks</description>
    <arm_group_label>Baduanjin Exercise and Instrument Rehabilitation</arm_group_label>
    <arm_group_label>Baduanjin exercise group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Instrument rehabilitation</intervention_name>
    <description>Participants received pulmanory rehabilitation by using tri-ball respiratory trainer. Each instrument exercise session lasts 30 minutes and continues twice a day, 5 times per week for 12 weeks</description>
    <arm_group_label>Baduanjin Exercise and Instrument Rehabilitation</arm_group_label>
    <arm_group_label>Instrument rehabilitation group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged from 40 to 80 years

          -  Diagnosed with stable chronic obstructive pulmonary disease

          -  Phase II~III

        Exclusion Criteria:

          -  The condition was serious or movement restrained by other diseases

          -  In the acute exacerbation of chronic obstructive pulmonary disease

          -  Participants who have contraindications to exercise training

          -  Patients who have other serious acute, chronic organic disease or mental disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei Zhang, Master</last_name>
    <role>Study Chair</role>
    <affiliation>Shanghai Shuguang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Meng Sun, Master</last_name>
    <phone>86-21-20256375</phone>
    <email>gulik002@aliyun.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai Shuguang Hospital</name>
      <address>
        <city>Shanghai</city>
        <zip>201203</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Meng Sun, Master</last_name>
      <phone>86-21-20256375</phone>
      <email>gulik002@aliyun.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 26, 2019</study_first_submitted>
  <study_first_submitted_qc>March 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2019</study_first_posted>
  <last_update_submitted>March 28, 2019</last_update_submitted>
  <last_update_submitted_qc>March 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>ShuGuang Hospital</investigator_affiliation>
    <investigator_full_name>Sun Meng</investigator_full_name>
    <investigator_title>Attending Physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

